-
公开(公告)号:WO2021097212A1
公开(公告)日:2021-05-20
申请号:PCT/US2020/060421
申请日:2020-11-13
Applicant: AMGEN INC.
Inventor: PARSONS, Andrew T. , BEAVER, Matthew
IPC: C07D471/04 , C07F5/02 , C07F5/05
Abstract: The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2,2',2"-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-fluorophenol), useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.
-
公开(公告)号:WO2022076623A1
公开(公告)日:2022-04-14
申请号:PCT/US2021/053859
申请日:2021-10-06
Applicant: AMGEN INC.
Inventor: BEAVER, Matthew G. , CORBETT, Michael T. , FANG, Yuanqing , FORD, David D. , PARSONS, Andrew T. , ST-PIERRE, Gabrielle , TELMESANI, Reem
IPC: C07D471/04
Abstract: Provided herein is a process comprising heating a composition comprising (P)-compound A or a salt thereof and a solvent to a temperature of 250°C to 350°C to form racemized compound A. Also provided is a process for isolating (P)-compound A from a composition comprising (P)‑compound A and a tartrate, as described herein. Further provided herein, is a process for isolating a free acid of a tartrate or a hydrate thereof from a composition comprising a tartrate, (P)‑compound A, and an organic solvent. [Insert Structure] (A).
-
3.
公开(公告)号:WO2022109242A1
公开(公告)日:2022-05-27
申请号:PCT/US2021/060048
申请日:2021-11-19
Applicant: AMGEN INC.
Inventor: ACHMATOWICZ, Michal , COYLER, John T. , CORBETT, Michael T. , GRIFFIN, Daniel J. , PARSONS, Andrew T. , ROBINSON, Joanna , QUASDORF, Kyle
IPC: C07D471/04
Abstract: Provided herein is a process for preparing compound A comprising (a) admixing 2-isopropyl-4-methylpyridin-3-amine (Compound B), or a salt thereof, a first base, and a reactive compound comprising phosgene or a phosgene equivalent in an organic solvent to form 3‑isocyanato-2-isopropyl-4-methylpyridine (Compound C); (b) admixing Compound C and 2,6-dichloro-5-fluoronicotinamide (Compound D) to form 2,6-dichloro-5-fluoro-N-((2-isopropy1-4-methylpyridin-3-yl)carbamoyl)nicotinamide (Compound E); and (c) admixing Compound E and a second base to form a product mixture comprising Compound A and the second base. Also provided herein is a process for synthesizing AMG 510 comprising using Compound A prepared according to the disclosed processes [Insert Structure] (Compound A).
-
4.
公开(公告)号:EP4247813A1
公开(公告)日:2023-09-27
申请号:EP21827309.2
申请日:2021-11-19
Applicant: Amgen, Inc
Inventor: ACHMATOWICZ, Michal , COYLER, John T. , CORBETT, Michael T. , GRIFFIN, Daniel J. , PARSONS, Andrew T. , ROBINSON, Joanna , QUASDORF, Kyle
IPC: C07D471/04
-
公开(公告)号:EP4225755A1
公开(公告)日:2023-08-16
申请号:EP21802088.1
申请日:2021-10-06
Applicant: Amgen Inc.
Inventor: BEAVER, Matthew G. , CORBETT, Michael T. , FANG, Yuanqing , FORD, David D. , PARSONS, Andrew T. , ST-PIERRE, Gabrielle , TELMESANI, Reem
IPC: C07D471/04
-
公开(公告)号:EP4058453A1
公开(公告)日:2022-09-21
申请号:EP20821492.4
申请日:2020-11-13
Applicant: Amgen Inc.
Inventor: PARSONS, Andrew T. , BEAVER, Matthew
IPC: C07D471/04 , C07F5/02 , C07F5/05
-
-
-
-
-